In This Section

Pharmacology Repurposed: Novel Uses for Current Therapies

Tuesday April 09, 2019

2:00 pm - 3:30 pm Eastern Time (ET)

Room W205 A


Chair :

Joseph Provost
University of San Diego

Margaret Zimmerman
Tulane Univ

Many therapeutic agents are being repurposed, a process that uses a drug already approved to treat one condition/disease and safely applying it to another. The incorporation of repurposed drugs can be applied at all levels of research and promotes the development of new therapeutic approaches. Additionally, this methodology encourages researchers to investigate alternative pathways when targeting diseases. The goal of this symposium is to highlight both clinical and basic researchers that are using this approach, and to promote the NIH NCATS program which supports clinical and translational research in drug repurposing.


Jennifer Sasser - University of Mississippi Medical Center

NO More PDE5 in PE: Repurposing Sildenafil for Treatment of Preeclampsia

Andrew Haak - Mayo Clinic

Repurposing GPCRs to Regulate YAP/TAZ in Tissue Fibrosis

Last Updated: August 15, 2019
Key Dates
April 6

ASPET Business Meeting and Awards Presentation

April 6-9

ASPET Annual Meeting at EB 2019